Nebraska Cancer Specialists - Midwest Cancer Center - Legacy — Omaha, Nebraska

Nebraska Cancer Specialists - Midwest Cancer Center - Legacy is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Nebraska Cancer Specialists - Midwest Cancer Center - Legacy has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Colorectal Cancer, Metastatic Colorectal Cancer, Cancer Harboring BRAF Alterations.

Sponsors: Cardiff Oncology, Fore Biotherapeutics, Mirati Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Cancer Specialists - Midwest Cancer Center - Legacy?

Nebraska Cancer Specialists - Midwest Cancer Center - Legacy has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Cancer Specialists - Midwest Cancer Center - Legacy conducted?

Nebraska Cancer Specialists - Midwest Cancer Center - Legacy has 3 clinical trials on record, with 2 currently active. Their work covers Colorectal Cancer, Metastatic Colorectal Cancer, Cancer Harboring BRAF Alterations.

Is Nebraska Cancer Specialists - Midwest Cancer Center - Legacy accredited by Crixeo Health?

Nebraska Cancer Specialists - Midwest Cancer Center - Legacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Cancer Specialists - Midwest Cancer Center - Legacy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.